Company Overview and News

 
Archrock (AROC) Shares March Higher, Can It Continue?

2018-04-16 zacks
As of late, it has definitely been a great time to be an investor in Archrock, Inc. (AROC - Free Report) . The stock has moved higher by 7.6% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.
Upvote Downvote

 
Can The Uptrend Continue for Synchronoss Technologies (SNCR)?

2018-04-16 zacks
Investors certainly have to be happy with Synchronoss Technologies, Inc. (SNCR - Free Report) and its short term performance. After all, the stock has jumped by 12.2% in the past 4 weeks, and it is also above its 20 Day Simple Moving Average as well. This is certainly a good trend, but investors are probably asking themselves, can this positive trend continue for SNCR?
Upvote Downvote

 
Will Natural Resource Partners (NRP) Continue to Surge Higher?

2018-04-16 zacks
As of late, it has definitely been a great time to be an investor in Natural Resource Partners L.P. (NRP - Free Report) . The stock has moved higher by 17.9% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.
Upvote Downvote

 
Can the Rally in Bancolombia (CIB) Shares Continue?

2018-04-16 zacks
Bancolombia S.A. (CIB - Free Report) has been on the move lately as the stock has risen by 15.7% in the past four weeks, and it is currently trading well above its 20-Day SMA. This is a pretty solid move higher, but the question that has to be on investors’ minds right now is; can this trend continue?
Upvote Downvote

 
Why Copart, Inc. (CPRT) is Poised to Beat Earnings Estimates Again

2018-04-13 zacks
Looking for a stock that might be in a good position to beat earnings at its next report? Consider Copart, Inc. (CPRT - Free Report) , a firm in the Auction and Valuation Services industry, which could be a great candidate for another beat. This company has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. In fact, in these reports, CPRT has beaten estimates by at least 20% in both cases, suggesting it has a nice short-term history of crushing expectations.
Upvote Downvote

 
CORI / Corium International, Inc. 8-K (Current Report)

2018-03-27 sec.gov
cori_Current_Folio_8K UNITED STATES
Upvote Downvote

 
CORI / Corium International, Inc. 8-K (Current Report)

2018-03-20 sec.gov
cori_Current_Folio_8K_20180320 U
Upvote Downvote

 
CORI / Corium International, Inc. 8-K (Current Report)

2018-03-16 sec.gov
cori_Current_Folio_8K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20
Upvote Downvote

1
CORI / Corium International, Inc. / Ridgeback Capital Investments L.P. - SCHEDULE 13G (Passive Investment)

2018-03-15 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 &nb
Upvote Downvote

1
CORI / Corium International, Inc. / Ridgeback Capital Investments L.P. - SCHEDULE 13G (Passive Investment)

2018-03-15 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 &nb
Upvote Downvote

 
 
CORI / Corium International, Inc. 8-K (Current Report)

2018-03-01 sec.gov
cori_Current_Folio_8k UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8‑K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): March 1, 2018 Corium International, Inc. (Exact name of registrant as specified in its charter) Delaware 001‑36375 38‑3230774 (State or other jurisdiction of incorporation or organization) (Commission File Number) (I.
Upvote Downvote

 
CORI / Corium International, Inc. 8-K (Current Report)

2018-02-28 sec.gov
cori_Current Folio_8K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): February 28, 2018 Corium International, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36375 38-3230774 (State or other jurisdiction of incorporation or organization) (Commission File Number) (I.
Upvote Downvote

Related Articles

LPCN: Lipocine Inc Analysis and Research Report

2h - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

CUSIP: 21887L107